Location History:
- Frederick, MD (US) (2008)
- Dickerson, MD (US) (2012 - 2013)
Company Filing History:
4 out of 4 
4 out of 38 
Years Active: 2008-2013
Title: The Innovations of Randall K. Lapcevich
Introduction
Randall K. Lapcevich is an accomplished inventor based in Dickerson, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of protective antigens. With a total of 4 patents to his name, Lapcevich's work has had a notable impact on vaccine development and public health.
Latest Patents
One of his latest patents involves the preparation of a protective antigen. This patent provides a polynucleotide sequence that encodes recombinant Protective Antigen (rPA). Additionally, it includes expression vectors and host cells that comprise the polynucleotide sequence of the invention, along with methods for producing rPA. This innovation is crucial for advancing vaccine technologies and enhancing immune responses.
Career Highlights
Throughout his career, Lapcevich has worked with several prominent organizations. He has been associated with Dynport Vaccine Company LLC, where he contributed to vaccine development efforts. He also worked with the Health Protection Agency, further solidifying his expertise in the field of health and safety.
Collaborations
Lapcevich has collaborated with notable professionals in his field, including Ian McEntee and Philip Vincent. These collaborations have likely enriched his research and contributed to the success of his innovations.
Conclusion
Randall K. Lapcevich's contributions to biotechnology and vaccine development are commendable. His patents and collaborations reflect his dedication to advancing public health through innovative solutions.